- recruitingPHASE2
A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
This study looks into a new medicine called IPN10200, given as injections, to see if it can prevent migraine headaches in adults. It will check if the treatment is safe and how well it works for people who get migraines often.
United States · Australia · Brazil - recruitingPHASE3
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic Migraine
This study is testing a new injection called Xeomin to see if it can help reduce the number of migraine days for people who experience episodic migraines. We want to find out if it's safe and effective compared to a dummy injection.
United States · Austria · Canada - recruitingPHASE3
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
This study looks at a medicine called atogepant for children and teenagers aged 6 to 17 who get occasional migraines. It will check if the medicine is safe and if it helps reduce migraines, as there aren't many approved treatments for young people.
United States · Belgium · Canada - authorisedTherapeutic exploratory (Phase II)
OmaMig Pilot: An open-label, phase IIa, single arm pilot study evaluating the potential clinical benefit and safety of omalizumab in adults with episodic migraine.
This study is testing a new medicine called omalizumab (also known as Xolair) for adults who get migraine headaches regularly. We want to see if it reduces the number of migraine days and if it's safe to use.
Norway - recruitingPHASE3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
This study is looking into a new medicine called eptinezumab to see if it can help children and teenagers aged 6 to 17 reduce how often they get episodic migraines. Researchers want to know if it makes a real difference compared to a dummy treatment.
United States · Argentina · Canada